ATE295169T1 - Arzneimittel gegen infertilität, die mit endometriose assoziiert ist - Google Patents

Arzneimittel gegen infertilität, die mit endometriose assoziiert ist

Info

Publication number
ATE295169T1
ATE295169T1 AT98904958T AT98904958T ATE295169T1 AT E295169 T1 ATE295169 T1 AT E295169T1 AT 98904958 T AT98904958 T AT 98904958T AT 98904958 T AT98904958 T AT 98904958T AT E295169 T1 ATE295169 T1 AT E295169T1
Authority
AT
Austria
Prior art keywords
relates
endometriosis
drugs
pharmaceutical composition
infertility associated
Prior art date
Application number
AT98904958T
Other languages
English (en)
Inventor
Greta Edelstam
Original Assignee
Edelstam Inc
Greta Edelstam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edelstam Inc, Greta Edelstam filed Critical Edelstam Inc
Application granted granted Critical
Publication of ATE295169T1 publication Critical patent/ATE295169T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AT98904958T 1997-02-15 1998-02-09 Arzneimittel gegen infertilität, die mit endometriose assoziiert ist ATE295169T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,737 US5977143A (en) 1997-02-15 1997-02-15 Medicament against infertility which reduces phagocytosis of spermatozoa in women
PCT/US1998/002267 WO1998035676A1 (en) 1997-02-15 1998-02-09 A medicament against infertility and for increasing fertility

Publications (1)

Publication Number Publication Date
ATE295169T1 true ATE295169T1 (de) 2005-05-15

Family

ID=25179227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904958T ATE295169T1 (de) 1997-02-15 1998-02-09 Arzneimittel gegen infertilität, die mit endometriose assoziiert ist

Country Status (23)

Country Link
US (1) US5977143A (de)
EP (1) EP1001771B1 (de)
JP (1) JP3497513B2 (de)
KR (1) KR20000071053A (de)
CN (1) CN1248915A (de)
AT (1) ATE295169T1 (de)
AU (1) AU743346B2 (de)
BR (1) BR9807370A (de)
CA (1) CA2280685C (de)
DE (1) DE69830176T2 (de)
EE (1) EE9900346A (de)
ES (1) ES2245022T3 (de)
HU (1) HUP0001342A3 (de)
IL (1) IL131267A0 (de)
IS (1) IS5152A (de)
LT (1) LT4661B (de)
LV (1) LV12450B (de)
NO (1) NO321663B1 (de)
NZ (1) NZ337504A (de)
PL (1) PL335419A1 (de)
SK (1) SK110599A3 (de)
TR (1) TR199901958T2 (de)
WO (1) WO1998035676A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE305784T1 (de) * 1997-02-15 2005-10-15 Edelstam Inc Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
WO2011145993A1 (en) * 2010-05-19 2011-11-24 Isifer Ab Treatment for reducing inflammation
MX383743B (es) * 2015-10-23 2025-03-14 Isifer Ab Composicion para administracion abdominal.
KR101802090B1 (ko) 2016-09-26 2017-11-27 서울대학교산학협력단 탈락막 자궁내막 세포를 포함하는 자궁내막 손상의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
FR2704147B1 (fr) * 1993-04-22 1995-07-21 Leguern Jacques Composition régénératrice des cellules et son application en milieu médical, vétérinaire et agricole.

Also Published As

Publication number Publication date
LT4661B (lt) 2000-05-25
NZ337504A (en) 2001-01-26
IS5152A (is) 1999-08-11
ES2245022T3 (es) 2005-12-16
WO1998035676A1 (en) 1998-08-20
DE69830176D1 (de) 2005-06-16
IL131267A0 (en) 2001-01-28
HUP0001342A3 (en) 2000-10-30
AU6270398A (en) 1998-09-08
JP3497513B2 (ja) 2004-02-16
NO321663B1 (no) 2006-06-19
HUP0001342A2 (hu) 2000-09-28
BR9807370A (pt) 2000-03-14
LV12450B (en) 2000-10-20
EP1001771A1 (de) 2000-05-24
US5977143A (en) 1999-11-02
LT99101A (en) 2000-03-27
EP1001771A4 (de) 2000-09-27
CA2280685C (en) 2004-06-29
NO993921L (no) 1999-08-13
AU743346B2 (en) 2002-01-24
DE69830176T2 (de) 2006-01-26
LV12450A (lv) 2000-04-20
KR20000071053A (ko) 2000-11-25
TR199901958T2 (xx) 1999-12-21
CN1248915A (zh) 2000-03-29
EE9900346A (et) 2000-02-15
EP1001771B1 (de) 2005-05-11
PL335419A1 (en) 2000-04-25
CA2280685A1 (en) 1998-08-20
JP2000513737A (ja) 2000-10-17
NO993921D0 (no) 1999-08-13
SK110599A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
ID29181A (id) Kombinasi formoterol dan garam tiotropium
MY126555A (en) Oral pharmaceutical extended release dosage form
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
AR024228A1 (es) Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico
GEP20043314B (en) Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa
AR002261A1 (es) Composicion en polvo para la administracion por inhalacion de polipeptidos utiles en medicina, metodos para la manufactura de dicha composicion, y uso de la composicion para la manufactura de un medicamento para el tratamietno de enfermedades a traves del tracto respiratorio
NZ514574A (en) Novel method of treatment
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
CY1108648T1 (el) Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
ATE295169T1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
IT1276031B1 (it) Composizione farmaceutica per il trattamento delle malattie autoimmuni
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
ATE305784T1 (de) Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
HUP9901474A2 (hu) Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiához
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
IT1306171B1 (it) Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
Finch Therapeutic targets in Alzheimer's disease: Suggestions for the NIA.
ECSP993215A (es) Nueva composicion y uso
ECSP982520A (es) Composicion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties